NeutriSci International Inc. (NU.V)
| Previous Close | 0.1300 |
| Open | 0.1350 |
| Bid | 0.1200 x 0 |
| Ask | 0.1350 x 0 |
| Day's Range | 0.1350 - 0.1350 |
| 52 Week Range | 0.1000 - 0.3500 |
| Volume | 700 |
| Avg. Volume | 104,560 |
| Market Cap | 20.778M |
| Beta (5Y Monthly) | 2.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0130 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Neutrisci Provides Update on Tabletz and Previously Announced Project Development
VANCOUVER, BC / ACCESSWIRE / July 7, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company")(TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to provide an update on previously announced projects.
- ACCESSWIRE
NeutriSci Provides Update On Biople Product Launch In Japan
VANCOUVER, BC / ACCESSWIRE / June 23, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU) (OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its partner, Tabletz LLC, is pleased to update details regarding the Biople launch of the TABLETZ brand in Japan.
- ACCESSWIRE
Neutrisci Ships Tabletz Rush Order to #1 CBD Retailer in Japan
VANCOUVER, BC / ACCESSWIRE / June 9, 2021 / NeutriSci International Inc. ('NeutriSci' or the 'Company') (TSXV:NU)(OTCQB:NRXCF)(FSE:1N9), an innovative technology company developing products, licensing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has finished production of the rush order placed by Tabletz LLC and shipped it via air freight to Japan.
